Prolonged remission of metastatic malignant fibrous histiocytoma induced by combination chemotherapy
✍ Scribed by Gerald H. Clamon; Robert A. Robinson; Elizabeth B. Olberding
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 739 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
✦ Synopsis
A patient with metastatic malignant fibrous histiocytoma (MFH) achieved a complete remission with polychemotherapy lasting 42+ months. In view of this long-term survival and two similar prior reports of long-term survival after aggressive treatment, the goal of therapy for metastatic MFH must be reconsidered.
📜 SIMILAR VOLUMES
## Abstract Malignant fibrous histiocytoma (MFH) of the bone is a high‐grade sarcoma characterized histologically by the composition of fibroblasts and pleomorphic cells with a prominent storiform pattern. Despite institution of multi‐modality treatments, the prognosis for patients with this tumor
## Abstract Cytokines are considered to play an important role in tumor pathogenesis and progression, and recent studies have demonstrated that a variety of forms, including interleukins (ILs) and transforming growth factor‐βs (TGF‐βs), may regulate tumors. In the present study, the expression of T